abstract |
Formula (I): Wherein R 1 -fluoro, chloro, C 1-3 alkyl and C 1-3 alkoxy are selected, R 2 -X- is methyl, methoxymethyl and And n is 0, 1 or 2. Or a salt, prodrug or solvate thereof. Also described is the use of the compound as a GLK activator, a pharmaceutical composition containing the compound, and a method for producing the compound. |